Health-related quality of life in meningioma

Sameah Haider1, Martin J B Taphoorn2,3, Katharine J Drummond4,5

  • 1Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.

Abstract

Insights

Treatment for symptomatic meningiomas improves health-related quality of life (HRQOL) and cognitive function. However, larger tumor size, specific locations, and higher tumor grade are linked to worse HRQOL in patients with meningiomas.

Area of Science:

  • Neurology
  • Oncology
  • Public Health

Background:

  • Meningiomas are the most common primary brain tumors in adults.
  • While often benign, they can cause significant functional impairment and affect well-being.
  • Patient-reported outcomes and health-related quality of life (HRQOL) are crucial for understanding meningioma's impact.

Purpose of the Study:

  • To explore the multidimensional nature of HRQOL in meningioma patients.
  • To understand how meningiomas and their treatments influence patient HRQOL.
  • To identify factors associated with better or worse HRQOL outcomes.

Main Methods:

  • Review of treatment strategies including observation, surgery, and radiation.
  • Examination of contributions to symptoms, physical and cognitive functioning, and daily life.
  • Analysis of patient-reported outcomes and health-related quality of life.

Main Results:

  • Treatment of symptomatic meningiomas is associated with improved HRQOL.
  • Improved cognitive functioning and seizure control are observed post-treatment.
  • Tumor characteristics like size, location, and histologic grade correlate with worse HRQOL.

Conclusions:

  • Symptomatic meningioma treatment positively impacts patient HRQOL and function.
  • Specific tumor-related factors significantly influence the patient's quality of life.
  • Understanding these factors is key for managing meningioma patient outcomes.

Related Concept Videos